Moreover, IPAH and HPAH patients with BMPR2 mutations had more severe haemodynamic and functional parameters than noncarriers, and those carriers were diagnosed at younger ages. This evidence concerns the gene BMPR2 and heritable pulmonary arterial hypertension.